Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Corium International Inc (NASDAQ: CORI) acted responsibly on behalf of investors’ profitability in the planned sale to Gurnet Point Capital.

On October 11, 2018, Corium International Inc (NASDAQ: CORI) and Gurnet Point Capital announced that they had entered into a merger agreement. Under the terms of the merger agreement, Gurnet will offer Corium shareholders $21.50 per share in cash for all outstanding shares.    

Based in Menlo Park, California, and founded in 1995 Corium International Inc focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems.

The investigation focuses on whether NASDAQ: CORI investors received the highest price and whether the directors of Corium International Inc acted in the best interest of Corium International Inc company and its shareholders.   

If you purchased Corium International Inc (NASDAQ: CORI) prior to October 11, 2018, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185